Abstract
The detection and management of prostate cancer have improved considerably in the past decade and will be even more sharply defined in the future. Radiolabelled monoclonal antibodies are now available to detect occult soft tissue lesions of prostate cancer clinically by SPEC scanning. Lesions in lymph nodes and bone marrow are now visualised months before conventional techniques confirm this opportunity. As a result, the staging and earlier treatment of regionalised disease is possible.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Murphy, G.P. (1994). Prostate Cancer 2000: Projections for the Future. In: Denis, L. (eds) Prostate Cancer 2000. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79178-9_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-79178-9_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79180-2
Online ISBN: 978-3-642-79178-9
eBook Packages: Springer Book Archive